354200 — NGeneBio Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for NGeneBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-6,865	-8,228	-8,431	-9,839	-12,860
Depreciation
Amortisation
Non-Cash Items	2,985	3,050	841	2,290	1,666
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-290	-900	-963	-1,545	683
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-3,553	-5,428	-7,523	-7,820	-9,167
Capital Expenditures	-4,961	-651	-3,372	-1,225	-828
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,301	2,770	-14,006	1,810	4,959
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7,261	2,119	-17,378	585	4,131
Financing Cash Flow Items	58.1	—	—	130	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	5,822	40,697	1,895	15,797	-608
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-4,992	37,388	-23,006	8,601	-5,623